These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 23764565

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 7. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies.
    Thase ME, Shelton RC, Khan A.
    J Clin Psychopharmacol; 2006 Jun; 26(3):250-8. PubMed ID: 16702889
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder.
    Fagiolini A, Cardoner N, Pirildar S, Ittsakul P, Ng B, Duailibi K, El Hindy N.
    Expert Opin Pharmacother; 2023 Jun; 24(15):1715-1723. PubMed ID: 37501324
    [Abstract] [Full Text] [Related]

  • 13. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR, Arikian SR, Casciano J, Doyle JJ.
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [Abstract] [Full Text] [Related]

  • 14. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G, Saint-André E, Hébert C, de Montigny C, Lavoie N, Blier P.
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [Abstract] [Full Text] [Related]

  • 15. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F.
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract] [Full Text] [Related]

  • 16. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA, Andersen HF.
    Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
    [Abstract] [Full Text] [Related]

  • 17. Hyponatremia with venlafaxine.
    Masood GR, Karki SD, Patterson WR.
    Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.
    Sáiz-Ruiz J, Ibáñez A, Díaz-Marsá M, Arias F, Padín J, Martín-Carrasco M, Montes JM, Ferrando L, Carrasco JL, Martín-Ballesteros E, Jordá L, Chamorro L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1129-34. PubMed ID: 12452535
    [Abstract] [Full Text] [Related]

  • 19. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
    Weiss NT, Jones L, Chamberlain JC.
    J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.
    Bradley RH, Barkin RL, Jerome J, DeYoung K, Dodge CW.
    Am J Ther; 2003 Oct; 10(5):318-23. PubMed ID: 12975715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.